Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Neurogene Secures FDA Breakthrough Therapy Designation for NGN-401 in Rett Syndrome

Friday, February 27, 2026

Neurogene has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation to NGN its investigational gene therapy for Rett syndrome

Synthekine Enters into Collaboration with Merck to Advance STK-012 Combination in Phase 2 NSCLC Trial

Friday, February 27, 2026

Synthekine has entered into a clinical trial collaboration and supply agreement with Merck to evaluate STK in combination with Keytruda pembrolizumab and standard chemotherapy

Akeso Inc Secures NMPA Approval for Novel Bispecific Antibody Targeting Alzheimer's in China

Thursday, February 26, 2026

Akeso Incs innovative bispecific antibody AK targeting amyloidbeta and BBB receptor receives NMPA approval accelerating Alzheimers treatments in Asia

Antengene Enters into Collaboration with Junshi Biosciences to Evaluate ATG-037 and JS207 in Solid Tumours

Thursday, February 26, 2026

Antengene has entered into a clinical collaboration with Shanghai Junshi Biosciences to assess the combination of ATG and JS in patients with solid tumours in Mainland China

Frontier Biotech Enters into Agreement with GSK for siRNA Therapies

Thursday, February 26, 2026

Frontier Biotechnologies has entered into a global exclusive licensing agreement with GSK covering therapeutic applications based on small interfering RNA siRNA technology

China Launches Dual-Track Reimbursement System for Innovative Drugs to Boost Global Pharma Access

Wednesday, February 25, 2026

China has implemented a new dualtrack reimbursement system for innovative drugs accelerating market access and supporting global pharmaceutical manufacturers in the Asian region

Siren Biotechnology Receives FDA Fast Track Designation for SRN-101 for Recurrent High-Grade Glioma

Wednesday, February 25, 2026

Siren Biotechnology has received Fast Track Designation from the US Food and Drug Administration FDA for SRN its lead AAVbased immunogene therapy for the treatment of recurrent highgrade glioma HGG

Sciwind Biosciences Partners with Pfizer China to Commercialise its Biased GLP-1 in China

Wednesday, February 25, 2026

Hangzhou Sciwind Biosciences Co Ltd has entered into a strategic commercialisation agreement with Pfizer China for Ecnoglutide injection a nextgeneration cAMPbiased GLP receptor agonist

TIDES Asia 2026: Premier Summit on Oligonucleotide and Peptide Therapeutics Kicks Off in Tokyo Today

Tuesday, February 24, 2026

The TIDES Asia summit begins today in Tokyo uniting AsiaPacific biopharma leaders to advance oligonucleotide peptide mRNA and genome editing technologies

Formosa Pharmaceuticals Signs Licensing Deal with Arrotex for Commercialisation of Clobetasol Propionate Ophthalmic Suspension in Australia and New Zealand

Tuesday, February 24, 2026

Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Arrotex Pharmaceuticals Pty Ltd for the commercialisation of clobetasol propionate ophthalmic suspension APP in Australia and New Zealand The product is used to treat inf...